Pemvidutide's potential in obesity and MASH, combined with lean mass preservation, could make it a market leader in the ...

Eli Lilly surged 58% in 2024, driven by weight-loss drugs and strong earnings. The technical chart shows consolidation. See ...

Respondents predict that the highest rates will be reflected in all outpatient prescription drugs with an 11.4% increase, up ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...

While both berberine and Ozempic may lead to weight loss, they are very different things. It’s “inaccurate and misleading” to ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Due to increased demand, price hikes and long-term shortages, obtaining prescriptions for weight loss drugs such as ...

Three doctors have expressed concerns to Newsweek about weight loss drugs for children, with research suggesting an initial reluctance to prescribe them.

Patients taking GLP-1s had a 15-20% reduction in MACE (heart attack and stroke ... This marked the first time that any weight ...

Treatments like GLP-1s are effective, but they're also extremely expensive. With GLP-1s rising in demand, it can pose a ...

Can a popular medication used to change your body also be affecting your mood? It’s a question that some users of semaglutide ...

Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...